ArticleInfectious Disease Modelling2026
Optimizing spatiotemporal nonpharmaceutical interventions for influenza: An adaptive reinforcement learning approach for regional heterogeneity.
Article in Infectious Disease Modelling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring epidemic control policies using nonlinear programming and mathematical models.PLoS computational biology · 2026Article
- Forecasting Influenza Epidemics and Pandemics in the Age of AI and Machine Learning.Reviews in medical virology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Influenza remains a significant global public health challenge because of its high transmissibility, widespread circulation, and considerable societal impact. Conventional threshold-based nonpharmaceutical interventions (NPIs) provide valuable frameworks for outbreak control; however, these standardized approaches may not fully account for important regional heterogeneity. It remains difficult to weigh regional characteristics and accurately balance infection control and socioeconomic costs. Methods: We propose a susceptible-exposed-infectious-quarantined-removed compartmental model-dueling deep Q-network (SEIQR-Dueling DQN) framework tailored to plains, hilly, and plateau cities. By integrating climatic, demographic, and health care resource data, the model captures regional differences in transmission and recovery dynamics. A multidimensional state space and discrete intervention set allow for the adaptive optimization of NPI strategies across varying epidemic and resource conditions. Model parameters were estimated by sequential Bayesian optimization, and bootstrap resampling was used to quantify uncertainty. In addition, the performance of the SEIQR-Dueling DQN strategy was compared with that of the threshold-based strategy in terms of the reduction in cumulative infections, peak prevalence and length of intervention periods. Results: The threshold-based intervention policy reduced cumulative infections by 3.05 %-3.67 % and peak incidence by 8.26 %-12.58 % but showed limited responsiveness to regional variation, often resulting in either under- or over-control. The SEIQR-Dueling DQN framework dynamically adjusted intervention timing and combinations on the basis of local demographic structures and epidemic trends and reduced cumulative infections by 5.87 %, 5.99 %, and 5.21 % in plains, hilly, and plateau cities, respectively, while achieving peak reductions of 34.92 %, 22.23 %, and 8.12 %, respectively, with a balanced consideration of socioeconomic impact. To assess generalizability, the trained model was applied to cities with differing transmission dynamics and demonstrated consistent performance across settings. Conclusion: The SEIQR-Dueling DQN framework supports tailored interventions across regions and shows promise for broader application in the management of regional heterogeneity and future emerging infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.